Endometrial Cancer Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Doctors expect you to live for at least 90 days.
• You have been diagnosed (confirmed by a tissue sample/biopsy) with an advanced cancer that has spread, located somewhere between your upper chest and pelvis, and it has continued to grow after standard treatments and cannot be removed by surgery or other local treatments.
• Your cancer can be measured on a scan using a standard medical measurement system (called RECIST 1.1).
• Your cancer has continued to grow despite standard available treatments, or you were unable to tolerate those treatments, and it cannot be cured.
• Any side effects from your previous cancer treatments have fully cleared up, and at least 14 days have passed since your last cancer treatment or radiotherapy.
• A scan (CT, MRI, or PET/CT) has confirmed your cancer has continued to grow since your last treatment.
• You have no history of cancer spreading to the brain, confirmed by a scan taken within 30 days before starting treatment.
• You have had a CT scan for treatment planning done within 14 days before starting the study treatment.
• You are 18 years of age or older.
• The measurement around your rib cage is 90 cm (about 35.5 inches) or less.
• You are generally well enough to carry out some daily activities (confirm with trial site regarding the specific fitness level required).
• Your blood, liver, and kidney functions meet certain minimum levels measured by blood tests on the day of screening and the day of the procedure.
• You are able and willing to sign a written consent form agreeing to take part.
• You do not have any electronic devices, electrically conductive implants, or metal objects inside your body, confirmed by a CT scan review and a questionnaire you complete.

Who may not be able to join:

• You have received chemotherapy, radiotherapy, or hormonal therapy within the last 14 days before screening.
• You have received immunotherapy, biological therapy, or any other experimental treatment within the last 21 days before screening.
• You are still experiencing side effects from previous cancer treatments that are more than mild in severity.
• You currently have cancer that has spread to the brain, or you have a prior history of cancer spreading to the brain.
• You have a known history of allergic reactions to similar types of compounds used in this study (confirm with trial site for specific details).
• You have another serious illness that is not under control — such as an active infection, heart problems, or a mental health condition — that the study doctor believes could put you at risk or make it hard for you to follow the study requirements.
• You are currently pregnant or breastfeeding.
• You are unwilling to abstain from sex or use contraception for up to 30 days after your last study treatment.
• You have any electronic devices, electrically conductive implants, or metal objects inside your body.
• Your rib cage circumference is more than 90 cm (about 35.5 inches).
• You are unable to sign a written consent form.
• You are unable to lie flat on your back with your arms extended above your head.

Important: Always verify eligibility with the trial site directly before applying.